E3	Procedure:T3
E5	Or:T5 Arg:T47 Arg2:T48
E6	Eq-Comparison:T6 Operator:T49 Value:T50 Temporal-Unit:T51
E7	Condition:T7 Name:T52
E8	And:T8 Arg:E7 Arg2:E47
E9	Drug:T9 Name:T53 Temporality:E10 Duration:E11
E10	Eq-Comparison:T10 Value:T54 Value:T55 Operator:T56 Per:T57
E11	Eq-Comparison:T11 Operator:T58 Value:T59 Temporal-Unit:T60
E12	Temporal-Connection:T12 Arg:E9
E13	Observation:T13 Name:T61 Temporality:E14
E14	Eq-Comparison:T14 Value:T63 Temporal-Unit:T64 Operator:T62
E15	Temporal-Connection:T15 Arg:E14 Arg2:E16
E16	Eq-Comparison:T16 Temporal-Recency:T82
E17	Drug:T17 Name:T83
E18	Eq-Comparison:T18 Temporal-Period:T66
E19	Study:T19 Temporality:E18
E20	Condition:T20 Name:T67
E21	Modifier:T21
E22	Or:T22 Arg:E21 Arg2:E23
E23	Condition:T23 Name:T68
E24	Study:T24
E25	Study:T25 Study-Of:E27
E27	Drug:T27 Temporality:E28
E28	Eq-Comparison:T28 Operator:T69 Value:T70 Temporal-Unit:T71
E29	Temporal-Connection:T29 Arg:E28 Arg2:E30
E30	Eq-Comparison:T30 Temporal-Recency:T72
E31	Drug:T31 Name:T73
E33	Procedure:T33 Temporality:E30
E37	Condition:T37 Name:T75
E38	Drug:T38 Name:T76
E40	Or:T40 Arg:E38 Arg2:E32
E42	Condition:T42 Name:T78
E43	Or:T43 Arg:E42 Arg2:E44
E44	Assertion:T44 Asserted:E45
E45	Condition:T45 Name:T79
E1	Drug:T1 Name:T2
E2	Assertion:T46 Asserted:E3
E4	Age:T4 Eq-Comparison:E6
E46	Modifier:T80 Modifies:T52
E47	Procedure:T81
E48	Procedure:T65 Temporality:E16
E26	Or:T26 Arg:E24 Arg2:E25
E32	Coreference:T32 Refers-To:E38
T3	Procedure 233 224	treatment
T5	Or 423 413	or
T6	Eq-Comparison 467 455	greater than or equal to 19 years
T7	Condition 544 531	diabetes
T8	And 548 535	and
T9	Drug 575 562	basal insulin
T10	Eq-Comparison 621 604	1-3 bolus insulin injections per day
T11	Eq-Comparison 644 626	at least 24 weeks
T12	Temporal-Connection 653 635	prior to
T13	Observation 707 688	HbA1c
T14	Eq-Comparison 745 725	less than or equal to 12 weeks
T15	Temporal-Connection 754 734	prior to
T16	Eq-Comparison 765 745	initiation
T17	Drug 781 760	NovoMix® 30
T18	Eq-Comparison 827 804	Previous
T19	Study 855 832	study
T20	Condition 953 928	Mental incapacity
T21	Modifier 969 943	unwillingness
T22	Or 972 946	or
T23	Condition 990 964	language barriers
T24	Study 1080 1054	clinical trial
T25	Study 1129 1102	investigational
T27	Drug 1147 1120	medicinal product
T28	Eq-Comparison 1164 1136	within 24 weeks
T29	Temporal-Connection 1173 1145	prior to
T30	Eq-Comparison 1184 1156	initiation
T31	Drug 1200 1171	NovoMix® 30
T33	Procedure 1210 1181	treatment
T37	Condition 1295 1262	Hypersensitivity
T38	Drug 1311 1277	NovoMix® 30
T40	Or 1314 1280	or
T42	Condition 1354 1320	Pregnancy
T43	Or 1357 1323	or
T44	Assertion 1367 1333	intention
T45	Condition 1388 1354	pregnant
T47	Life-Stage-And-Gender 420 410	Male
T48	Life-Stage-And-Gender 430 420	female
T49	Eq-Operator 454 443	greater than or equal
T50	Eq-Value 461 449	19
T51	Eq-Temporal-Unit 467 455	years
T52	Condition-Name 544 531	diabetes
T53	Drug-Name 575 562	basal insulin
T54	Eq-Value 583 569	1
T55	Eq-Value 588 571	3
T57	Eq-Temporal-Unit 621 604	day
T58	Eq-Operator 634 617	at least
T59	Eq-Value 638 620	24
T60	Eq-Temporal-Unit 644 626	weeks
T61	Observation-Name 707 688	HbA1c
T62	Eq-Operator 732 713	less than or equal
T63	Eq-Value 739 719	12
T64	Eq-Temporal-Unit 745 725	weeks
T66	Eq-Temporal-Period 827 804	Previous
T67	Condition-Name 953 928	Mental incapacity
T68	Condition-Name 990 964	language barriers
T69	Eq-Operator 1154 1127	within
T70	Eq-Value 1158 1130	24
T71	Eq-Temporal-Unit 1164 1136	weeks
T72	Eq-Temporal-Recency 1184 1156	initiation
T73	Drug-Name 1200 1171	NovoMix® 30
T75	Condition-Name 1295 1262	Hypersensitivity
T76	Drug-Name 1311 1277	NovoMix® 30
T78	Condition-Name 1354 1320	Pregnancy
T79	Condition-Name 1388 1354	pregnant
T1	Drug 274 264	NovoMix® 30
T2	Drug-Name 274 264	NovoMix® 30
T46	Assertion 223 214	decision to initiate
T4	Age 467 455	years
T80	Modifier 535 522	type 2
T81	Procedure 556 543	treated
T56	Eq-Operator 585 570	-
T82	Eq-Temporal-Recency 765 745	initiation
T83	Drug-Name 781 760	NovoMix® 30
T65	Procedure 791 770	treatment
T26	Or 1098 1072	or
T32	Coreference 1339 1305	excipients
A1	Temporal-Connection-Type-Value E12 before
A2	Temporal-Connection-Type-Value E15 before
A3	Temporal-Connection-Type-Value E29 before
A4	Assertion-Type-Value E44 intention
A5	Life-Stage-And-Gender-Type T47 male
A6	Life-Stage-And-Gender-Type T48 female
A7	Eq-Operator-Value T49 GTEQ
A8	Eq-Temporal-Unit-Value T51 year
A9	Eq-Temporal-Unit-Value T57 day
A10	Eq-Operator-Value T58 GTEQ
A11	Eq-Temporal-Unit-Value T60 week
A12	Observation-Type-Value T61 lab
A13	Eq-Operator-Value T62 LTEQ
A14	Eq-Temporal-Unit-Value T64 week
A15	Eq-Temporal-Period-Value T66 past
A16	Eq-Operator-Value T69 LTEQ
A17	Eq-Temporal-Unit-Value T71 week
A18	Eq-Temporal-Recency-Value T72 first-time
A19	Assertion-Type-Value E2 hypothetical
A20	Eq-Operator-Value T56 BETWEEN
A21	Eq-Temporal-Recency-Value T82 first-time
R1	Using Arg1:E3 Arg2:E1
R2	Using Arg1:E47 Arg2:E9
R3	Using Arg1:E48 Arg2:E17
R4	Using Arg1:E33 Arg2:E31
R5	Caused-By Arg1:E37 Arg2:E38
R6	Caused-By Arg1:E37 Arg2:E32